Lipopolysaccharide and Tumor Necrosis Factor Alpha Inhibit Interferon Signaling in Hepatocytes by Increasing Ubiquitin-Like Protease 18 (USP18) Expression

• Published in: Journal of virology 2016-06, Vol.90 (12), p.5549-5560
• Main Authors: MacParland, Sonya A, Ma, Xue-Zhong, Chen, Limin, Khattar, Ramzi, Cherepanov, Vera, Selzner, Markus, Feld, Jordan J, Selzner, Nazia, McGilvray, Ian D
• Format: Article
• Language: English
• Subjects: Animals; Cell Line, Tumor; Endopeptidases - genetics; Endopeptidases - metabolism; Hepacivirus - physiology; Hepatitis B virus; Hepatitis C virus; Hepatitis C, Chronic - immunology; Hepatocytes - immunology; Hepatocytes - metabolism; Hepatocytes - virology; Humans; Immunity, Innate; Inflammation - virology; Influenza virus; Interferon-alpha - genetics; Interferon-alpha - immunology; Interferon-alpha - metabolism; Interleukin-10 - pharmacology; Interleukin-6 - pharmacology; Ischemia - blood; Lipopolysaccharides - pharmacology; Liver - blood supply; Liver - immunology; Liver - injuries; Liver - pathology; Mice; Myxovirus Resistance Proteins - genetics; Myxovirus Resistance Proteins - metabolism; Pathogenesis and Immunity; Signal Transduction; STAT1 Transcription Factor - genetics; STAT1 Transcription Factor - metabolism; Tumor Necrosis Factor-alpha - pharmacology; Ubiquitin Thiolesterase - genetics; Ubiquitin Thiolesterase - metabolism
• ISSN: 0022-538X; 1098-5514
• DOI: 10.1128/jvi.02557-15

Inflammation may be maladaptive to the control of viral infection when it impairs interferon (IFN) responses, enhancing viral replication and spread. Dysregulated immunity as a result of inappropriate innate inflammatory responses is a hallmark of chronic viral infections such as, hepatitis B virus and hepatitis C virus (HCV). Previous studies from our laboratory have shown that expression of an IFN-stimulated gene (ISG), ubiquitin-like protease (USP)18 is upregulated in chronic HCV infection, leading to impaired hepatocyte responses to IFN-α. We examined the ability of inflammatory stimuli, including tumor necrosis factor alpha (TNF-α), lipopolysaccharide (LPS), interleukin-6 (IL-6) and IL-10 to upregulate hepatocyte USP18 expression and blunt the IFN-α response. Human hepatoma cells and primary murine hepatocytes were treated with TNF-α/LPS/IL-6/IL-10 and USP18, phosphorylated (p)-STAT1 and myxovirus (influenza virus) resistance 1 (Mx1) expression was determined. Treatment of Huh7.5 cells and primary murine hepatocytes with LPS and TNF-α, but not IL-6 or IL-10, led to upregulated USP18 expression and induced an IFN-α refractory state, which was reversed by USP18 knockdown. Liver inflammation was induced in vivo using a murine model of hepatic ischemia/reperfusion injury. Hepatic ischemia/reperfusion injury led to an induction of USP18 expression in liver tissue and promotion of lymphocytic choriomeningitis replication. These data demonstrate that certain inflammatory stimuli (TNF-α and LPS) but not others (IL-6 and IL-10) target USP18 expression and thus inhibit IFN signaling. These findings represent a new paradigm for how inflammation alters hepatic innate immune responses, with USP18 representing a potential target for intervention in various inflammatory states. Inflammation may prevent the control of viral infection when it impairs the innate immune response, enhancing viral replication and spread. Blunted immunity as a result of inappropriate innate inflammatory responses is a common characteristic of chronic viral infections. Previous studies have shown that expression of certain interferon-stimulated genes is upregulated in chronic HCV infection, leading to impaired hepatocyte responses. In this study, we show that multiple inflammatory stimuli can modulate interferon stimulated gene expression and thus inhibit hepatocyte interferon signaling via USP18 induction. These findings represent a new paradigm for how inflammation alters hepatic innate i